My Capstone project established a clinical project plan for a Phase 2 clinical trial utilizing combination or two monoclonal antibody products for the treatment of hepatocellular carcinoma. The clinical project plan included an analysis of the current unmet medical need for hepatocellular carcinoma patients and global incidence rates of the disease, a discussion of the current standard of care treatment and current products in development for hepatocellular carcinoma patients, and planning for clinical trial conduct and global regulatory submissions for a Phase 2 clinical trial.